Page last updated: 2024-08-26

8-chloro-cyclic adenosine monophosphate and Astrocytoma, Grade IV

8-chloro-cyclic adenosine monophosphate has been researched along with Astrocytoma, Grade IV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, J; Chen, F; Chen, W; Chen, Y; Chen, Z; Cheng, S; Gao, M; Gu, J; Hu, J; Li, K; Li, Y; Liang, J; Lin, Y; Liu, D; Lu, B; Lu, W; Luan, Y; Mai, J; Qiu, P; Sai, K; Sheng, L; Su, X; Tan, Y; Wang, J; Wu, S; Xiao, X; Xie, Z; Xing, F; Yan, G; Yin, W; Zhang, H; Zhu, S; Zhu, W1
Drabek, K; Medić-Mijacević, L; Pesić, M; Pietrzkowski, Z; Piperski, V; Rakić, L; Ruzdijić, S1

Other Studies

2 other study(ies) available for 8-chloro-cyclic adenosine monophosphate and Astrocytoma, Grade IV

ArticleYear
The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes.
    Cell reports, 2017, 01-10, Volume: 18, Issue:2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Astrocytes; Brain Neoplasms; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Gene Expression Profiling; Glial Fibrillary Acidic Protein; Glioblastoma; Glycolysis; Humans; Organelle Biogenesis; Oxidative Phosphorylation; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Proteomics; Signal Transduction; Xenograft Model Antitumor Assays

2017
8-Cl-cAMP and tiazofurin affect vascular endothelial growth factor production and glial fibrillary acidic protein expression in human glioblastoma cells.
    Anti-cancer drugs, 2000, Volume: 11, Issue:9

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Antineoplastic Agents; Cell Differentiation; Cell Division; Endothelial Growth Factors; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Lymphokines; Ribavirin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000